Business Context and Reporting Period
This Form 8-K is a current report filed by Pacific Biosciences of California, Inc. on May 21, 2013. The filing documents events occurring at the Company's 2013 Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes
- Board Resignation: Susan Siegel, a Class I director, resigned from the Board of Directors effective immediately prior to the Annual Meeting, as previously disclosed on March 7, 2013.
- Director Elections: William Ericson and David Botstein were duly elected as Class III directors.
- Accounting Firm Ratification: Shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2013.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the outcomes of shareholder votes and director departures.
Investor Verification Checklist
- Verify the voting results for the election of William Ericson and David Botstein as Class III directors.
- Confirm the ratification of Ernst & Young LLP as the independent auditor for the 2013 fiscal year.
- Review the prior March 7, 2013 Form 8-K for details regarding Susan Siegel's resignation.
- Note the significant number of broker non-votes (13,981,648) recorded for the director elections.